Masayuki Futagami

Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma

A. Ayhan, Tsui-Lien Mao, Tamer Seckin et al. · International Journal of Gynecological Cancer · 2012 · 170 citations · Full text

Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography

Shigemi Sato, Yoshihito Yokoyama, Tomomi Sakamoto et al. · Cancer · 2000 · 133 citations

Clofibric acid, a peroxisome proliferator–activated receptor α ligand, inhibits growth of human ovarian cancer

Yoshihito Yokoyama, Bing Xin, Tatsuhiko Shigeto et al. · Molecular Cancer Therapeutics · 2007 · 87 citations · Full text

The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer

Makito Mizunuma, Yoshihito Yokoyama, Masayuki Futagami et al. · International Journal of Clinical Oncology · 2015 · 83 citations

Cervical Cancer Management, Radiation Medicine, Cervical Cancer +11

Prognostic Significance of Vascular Endothelial Growth Factor and Its Receptors in Endometrial Carcinoma

Yoshihito Yokoyama, Shigemi Sato, Masayuki Futagami et al. · Gynecologic Oncology · 2000 · 62 citations

Angiogenesis, Medicine, Gynecology +10